A Novel Role for Raloxifene Nanomicelles in Management of Castrate Resistant Prostate Cancer
Figure 1
Release rate of raloxifene from SMA-Ral at pH 5.5, 6.8, and 7.4. The release of raloxifene was evaluated using dialysis method and compared to raloxifene present inside the dialysis bag at h. The released was assessed over a period of 5 days. Data are expressed as mean ± SEM () ( for pH 5.5 versus pH 6.8 and 7.4 from 24 to 120 h).
